JointHealth™ express September 30, 2020
ACE Releases 2020 Edition of The Arthritis Medications Report Card
Featuring latest public drug plan information, Report Card helps you evaluate where your province ranks in terms of providing reimbursement for medications to treat inflammatory forms of arthritis.
Arthritis Consumer Experts (ACE) has released a new edition of the Arthritis Medications Report Card, redesigned to make it easier for people living with inflammatory arthritis evaluate where their province ranks in terms of providing reimbursement for medications approved for inflammatory arthritis such as rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis and juvenile idiopathic arthritis. The 2020 edition of the ACE Arthritis Medications Report Card features a new look, highlighting each province, and a printer-friendly format to help make it more accessible.
For more information about the ACE Arthritis Medications Report Card and where your province ranks, please read ACE’s news release.
ACE Releases 2020 Edition of The Arthritis Medications Report Card
Featuring latest public drug plan information, Report Card helps you evaluate where your province ranks in terms of providing reimbursement for medications to treat inflammatory forms of arthritis.
Arthritis Consumer Experts (ACE) has released a new edition of the Arthritis Medications Report Card, redesigned to make it easier for people living with inflammatory arthritis evaluate where their province ranks in terms of providing reimbursement for medications approved for inflammatory arthritis such as rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis and juvenile idiopathic arthritis. The 2020 edition of the ACE Arthritis Medications Report Card features a new look, highlighting each province, and a printer-friendly format to help make it more accessible.
For more information about the ACE Arthritis Medications Report Card and where your province ranks, please read ACE’s news release.
Arthritis Consumer Experts
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealth™ information and education programs.